ZA784501B - Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof - Google Patents

Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof

Info

Publication number
ZA784501B
ZA784501B ZA784501A ZA784501A ZA784501B ZA 784501 B ZA784501 B ZA 784501B ZA 784501 A ZA784501 A ZA 784501A ZA 784501 A ZA784501 A ZA 784501A ZA 784501 B ZA784501 B ZA 784501B
Authority
ZA
South Africa
Prior art keywords
processesfor
derivatives
substituted
preparation
pharmaceutical compositions
Prior art date
Application number
ZA784501A
Other languages
English (en)
Inventor
K Schromm
V Jacobi
E Renth
A Mentrup
A Fuegner
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of ZA784501B publication Critical patent/ZA784501B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA784501A 1977-08-10 1978-08-09 Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof ZA784501B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772735919 DE2735919A1 (de) 1977-08-10 1977-08-10 Neue 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren

Publications (1)

Publication Number Publication Date
ZA784501B true ZA784501B (en) 1980-04-30

Family

ID=6016013

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA784501A ZA784501B (en) 1977-08-10 1978-08-09 Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof

Country Status (32)

Country Link
US (1) US4241068A (fi)
JP (1) JPS5430177A (fi)
AT (1) AT370415B (fi)
AU (1) AU520240B2 (fi)
BE (1) BE869640A (fi)
BG (1) BG30472A1 (fi)
CA (1) CA1111037A (fi)
CH (1) CH649289A5 (fi)
CS (1) CS202506B2 (fi)
DD (1) DD140351A5 (fi)
DE (1) DE2735919A1 (fi)
DK (1) DK148019C (fi)
ES (5) ES472143A1 (fi)
FI (1) FI71555C (fi)
FR (1) FR2400017A1 (fi)
GB (1) GB2002764B (fi)
GR (1) GR65024B (fi)
HU (1) HU179933B (fi)
IE (1) IE47228B1 (fi)
IT (1) IT1107960B (fi)
LU (1) LU80094A1 (fi)
MX (1) MX5672E (fi)
NL (1) NL7808319A (fi)
NO (1) NO152605C (fi)
NZ (1) NZ188101A (fi)
PH (1) PH19117A (fi)
PL (2) PL115889B1 (fi)
PT (1) PT68407A (fi)
SE (1) SE444170B (fi)
SU (2) SU735168A3 (fi)
YU (1) YU40832B (fi)
ZA (1) ZA784501B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100516A1 (de) * 1981-01-10 1982-08-12 C.H. Boehringer Sohn, 6507 Ingelheim Pyridylaminobenzoesaeuren, ihre herstellung und verwendung
FR2533567A1 (fr) * 1982-09-23 1984-03-30 Ki I Farmakologii 2-(orthocarboxyphenylamino)-6h-pyrimido (2,1-b)-quinazolone-6 et ses derives, leur procede de preparation et leur application therapeutique
US4610991A (en) * 1983-04-18 1986-09-09 Sterling Drug Inc. Antihypertensive pyridylaminobenzamide compounds
JPS60100559A (ja) * 1983-11-05 1985-06-04 Morishita Seiyaku Kk ２−アニリノ−１，６−ジヒドロ−６−オキソ−５−ピリミジンカルボン酸誘導体，その製法及び該化合物を含有する抗アレルギ−剤
US4584379A (en) * 1985-01-22 1986-04-22 Merrell Dow Pharmaceuticals Inc. Isoquinoline thromboxane synthetase inhibitors
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
GB9615950D0 (en) * 1996-07-30 1996-09-11 Univ Warwick Variable reluctance machines
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064259A (en) * 1963-12-19 1967-04-05 Union Pharma Scient Appl New derivatives of 2-anilino-nicotinic acid and process for their preparation
GB1162287A (en) * 1967-11-07 1969-08-20 Union Pharma Scient Appl New Salts of 2-Anilino-Nicotinic Acids
GB1264798A (fi) * 1968-07-10 1972-02-23
ES416847A1 (es) * 1973-07-12 1976-03-01 Hermes Sa Lab Procedimiento para la obtencion de derivados del acido ni- cotinico.

Also Published As

Publication number Publication date
BE869640A (fr) 1979-02-09
CH649289A5 (de) 1985-05-15
DD140351A5 (de) 1980-02-27
DK148019C (da) 1985-07-01
ES480623A1 (es) 1980-01-01
ES475457A1 (es) 1979-11-16
IE47228B1 (en) 1984-01-25
DE2735919C2 (fi) 1988-10-27
NZ188101A (en) 1981-01-23
NO152605B (no) 1985-07-15
SU735168A3 (ru) 1980-05-15
AT370415B (de) 1983-03-25
GB2002764B (en) 1982-08-04
BG30472A1 (en) 1981-06-15
MX5672E (es) 1983-12-08
CA1111037A (en) 1981-10-20
LU80094A1 (de) 1979-09-07
PH19117A (en) 1986-01-06
JPS5430177A (en) 1979-03-06
HU179933B (en) 1983-01-28
FR2400017A1 (fr) 1979-03-09
SU886743A3 (ru) 1981-11-30
FI71555B (fi) 1986-10-10
FI71555C (fi) 1987-01-19
US4241068A (en) 1980-12-23
SE7808530L (sv) 1979-02-11
AU520240B2 (en) 1982-01-21
YU40832B (en) 1986-06-30
IT1107960B (it) 1985-12-02
ATA549278A (de) 1982-08-15
GR65024B (en) 1980-06-16
DK351978A (da) 1979-02-11
JPS6231704B2 (fi) 1987-07-09
DK148019B (da) 1985-02-04
ES480622A1 (es) 1980-01-01
PL115889B1 (en) 1981-05-30
PL208942A1 (fi) 1979-12-03
SE444170B (sv) 1986-03-24
GB2002764A (en) 1979-02-28
CS202506B2 (en) 1981-01-30
IT7850642A0 (it) 1978-08-08
NL7808319A (nl) 1979-02-13
NO152605C (no) 1985-10-23
NO782707L (no) 1979-02-13
PL115778B1 (en) 1981-04-30
IE781618L (en) 1979-02-10
AU3877278A (en) 1980-02-14
YU191678A (en) 1983-01-21
DE2735919A1 (de) 1979-02-22
FI782039A (fi) 1979-02-11
FR2400017B1 (fi) 1983-03-11
ES472143A1 (es) 1979-03-16
ES475456A1 (es) 1979-05-01
PT68407A (de) 1978-09-01

Similar Documents

Publication Publication Date Title
DE3061960D1 (en) Novel derivatives of glycerin, their preparation and pharmaceutical compositions containing them
IL56411A (en) Derivatives of 4-amino-5-alkylsulphonyl-ortho-anisamides,their preparation and pharmaceutical compositions containing them
NZ188320A (en) Thienothiazine derivatives preparation and pharmaceutical compositions
IL54842A (en) 1-piperidino-phthalazine derivatives,their preparation and pharmaceutical compositions containing them
IL61307A (en) Derivatives of 6beta-hydroxyalkylpenicillanic acids,their preparation and pharmaceutical compositions containing them
DE2862419D1 (en) Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
IL49911A (en) 5-benzoyl-pyrrole-2-acetic acid derivatives, their preparation and pharmaceutical compositions containing them
IL55765A (en) Dehydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL54535A0 (en) Novel -lactam derivatives, their preparation and pharmaceutical compositions containing them
IL56421A (en) 4-pyridone-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL54859A (en) Derivatives of amidinopenicillanic acid,their production and pharmaceutical compositions containing them
ZA784501B (en) Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof
IL52638A0 (en) Novel olivanic acid derivatives their preparation and pharmaceutical compositions containing them
IL53766A0 (en) 4-diphenylmethylene-1-hydroxybenzyl-piperidine derivatives, their preparation and pharmaceutical compositions containing them
IL55857A (en) Benzodioxanylcarbonyl-piperazinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL53861A0 (en) Novel n-aralkylaniline derivatives, their preparation and pharmaceutical compositions containing them
IL55095A0 (en) Novel piperidino-propanol derivatives,their preparation and pharmaceutical compositions containing them
IL56461A0 (en) 1-naphthyl-acetic acid derivatives, their preparation and pharmaceutical compositions containing them
IL57735A (en) 7beta-aminothiazolyl-acetamido-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL55253A (en) Benzimidazole-2-methanol and benzimidazole-2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL55229A0 (en) New oxanilic acid derivatives,their preparation and pharmaceutical compositions containing them
IL54235A (en) Derivatives of 1-phenyl-2-amino-1,3-propanediol,their preparation and pharmaceutical compositions containing them
DE2862030D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
IL60513A (en) Dihydronicotinic acid derivatives,their preparation and pharmaceutical compositions containing them
IL54509A0 (en) Novel derivatives of 6,7-benzomorphane, their preparation and pharmaceutical compositions containing them